Skip to content

Prevention of Restenosis by Concomitant Tibial artery interventions after EndoVascular Treatment in FemoroPopliteal artery diseases complicated with Poor Runoff

Prevention of Restenosis by Concomitant Tibial artery interventions after EndoVascular Treatment in FemoroPopliteal artery diseases complicated with Poor Runoff - ConTibi-FP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013438
Enrollment
200
Registered
2014-03-17
Start date
2014-03-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral artery disease

Interventions

Randomized Control Arm with concomitant below the knee artery interventions Randomized Control Arm without concomitant below the knee artery interventions

Sponsors

Sakakibara Heart Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)patients required endovacular treatment for femoro-popliteal artery complicated with all ipsilateral below-the-knee artery feeding under anckle narrowed more than 90% 2)patients with agreement for this study

Exclusion criteria

Exclusion criteria: 1)Life expectancy within 6months 2)allergy of contrast agents 3)under 20 years old 4)inappropiriate patients determined from study director 5)patients unavailable of antiplatelet agents and anticoagulant 6)Critical limb ischemia patients that revascularization to below-the-knee artery is scheduled

Design outcomes

Primary

MeasureTime frame
Restenosis rate of the target femoro-popliteal artery by duplex scan at one year

Secondary

MeasureTime frame
death, myocardial infarction, bleeding lower limb event(revascularization, acute limb ischemia), lower limb amptation, lower limb sympton(WIQ score)

Countries

Japan

Contacts

Public ContactClinical Trials Support Office

Sakakibara Heart Institute Clinical Trials Support Office

tikenjim@shi.heart.or.jp042-314-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026